CME Presentations

Postpartum Depression (PPD)



  • Jennifer Caruso, DO

    Jennifer Caruso, DO

    Jennifer Caruso, DO

    Maternal Fetal Medicine Obstetrician & Gynecologist

    Jennifer Caruso, DO, completed her residency at Ascension St. John Macomb, and she was the first graduate of the Maternal Fetal Medicine fellowship at WellSpan York Hospital. Dr. Caruso returned to Ascension to practice Maternal Fetal Medicine. Her special interests are in fetal diagnosis through ultrasound and diagnostic testing, and management of maternal chronic conditions such as diabetes. Additionally, Dr. Caruso is Associate Program Director for a resident ob/gyn program affiliated with Michigan State University that holds 20 members. She is board certified in Obstetrics and Gynecology and Maternal Fetal Medicine. Dr. Caruso is an active member of the American College of Osteopathic Obstetricians and Gynecologists on the editorial and continuing medical education committees.
  • Kristina Deligiannidis, MD

    Kristina Deligiannidis, MD

    Kristina Deligiannidis, MD

    Director, Women’s Behavioral Health

    Kristina Deligiannidis, MD, is a reproductive psychiatrist and the Director of Women’s Behavioral Health at Zucker Hillside Hospital, Northwell Health in Queens, New York where she leads a federally funded research program in perinatal depression and the perinatal clinical care and training programs. She is a nationally-recognized leader in the field of perinatal depression and in novel therapeutics research. Dr. Deligiannidis has published numerous manuscripts and has given many oral presentations/research posters at local, national, and international scientific conferences. She is a Council member of the Society of Biological Psychiatry and a full Member of the American College of Neuropsychopharmacology, where she serves on several committees.

CME Information

Global LogoPQH Logo

Proactive Approaches for Postpartum Depression (PPD) Earlier Recognition and Changing Treatment Paradigms

This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with the Depression and Bipolar Support Alliance (DBSA) and the American College of Osteopathic Obstetricians and Gynecologists (ACOOG).


This activity is supported by an educational grant from Sage Therapeutics Inc. and Biogen.


This activity was released on April 7, 2022 and is valid until April 7, 2023. Requests for credit must be made no later than April 7, 2023.


The target audiences for the HCP activity are OB-GYNs, maternal fetal medicine specialists, psychiatrists, psychologists, primary care physicians, NPs, PAs, and mental-health specialists.


Postpartum depression (PPD) is one of the most common complications of childbirth and early evidence suggests that prevalence rates are increasing during the COVID-19 pandemic. Even as the pandemic has exacerbated risk factors that contribute to PPD, it remains widely underdiagnosed. Clinicians need strategies to recognize the risk factors and symptoms of PPD, diagnose it sooner, and effectively incorporate existing and emerging treatments into clinical practice.

Join an esteemed panel of clinicians and patient representatives to discuss the interplay of social, environmental, and neurochemical factors that contribute to the development of PPD. Panelists will describe the urgent need to screen perinatal women for PPD risk factors. In addition, the activity will explore the expanding pharmacologic landscape for PPD beyond selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs). Panelists will also review the safety and efficacy data related to the use of neuroactive steroids in the management of PPD, with an eye toward improving patient outcomes.


After completing this activity, the participant should be better able to:

  • Describe the burden of PPD and the impact of the COVID-19 pandemic on PPD incidence
  • Apply strategies for earlier recognition of PPD symptoms in pregnant women and new mothers
  • Evaluate clinical evidence for the role of neuroactive steroids in the treatment of PPD


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.


Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This activity should take approximately 60 minutes to complete.


In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.


Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.


There is no fee for this educational activity.


Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter Reported Financial Relationship
Jennifer K. Caruso, DO
Director Maternal Fetal Medicine
Ascension Providence
Southfield, MI
Contracted Research: Natera
Kristina M. Deligiannidis, MD
Director, Women’s Behavioral Health, Zucker Hillside Hospital, Northwell Health
Associate Professor of Psychiatry, Molecular Medicine and Obstetrics & Gynecology Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Consulting Fee: Sage Therapeutics, Inc; Brii Biosciences; GH Research, Ireland
Contracted Research: Sage Therapeutics, Inc; Nesos Corporation

The planners and managers have the following relevant financial relationships with ineligible companies:

Name of Planner or Manager Reported Financial Relationship
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Sumera Ackbarali Nothing to disclose
Bridget Griffin Nothing to disclose
Alissa Yost Nothing to disclose
Allison Burow – Patient Nothing to disclose
Sarah Santos – Patient Nothing to disclose
Shannon Berry – Patient Nothing to disclose


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Accreditation Support:

For information about the accreditation of this program, please contact Global at 303-395-1782 or

Technical Support:

For any technical issues or issues with your CME Certificate, please contact at 877-394-1306 or at